OUR PRODUCTS

MOBILE APPS

GENERAL INFO

QNCX

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Quince Therapeutics (QNCX) Earnings Date & Reports

Quince Therapeutics Inc is preclinical stage biopharmaceutical company focused on advancing precision therapeutics for debilitating and rare diseases... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

QNCX is expected to report earnings to fall 35.29% to -21 cents per share on November 13

Quince Therapeutics QNCX Stock Earnings Reports

Q3'25

Est.

$-0.22

Q2'25

Missed

by $0.08

Q1'25

Missed

by $0.15

Q4'24

Missed

by $0.10

Q3'24

Missed

by $0.03

The last earnings report on August 11 showed earnings per share of -34 cents, missing the estimate of -25 cents. With 112.57K shares outstanding, the current market capitalization sits at 84.73M.

View a ticker or compare two or three

Compare

QNCX

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For QNCX
(Try 14 days for Free)

Interact to see
Advertisement

A.I.Advisor

published price charts

These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. QNCX showed earnings on August 11, 2025. You can read more about the earnings report here.

View AI-Driven Trading

A.I. Advisor

published General Information

General Information

a developer of novel disease-modifying therapeutic for alzheimer's and other degenerative diseases

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Biotechnology

Address

611 Gateway Boulevard

Phone

+1 415 910-5717

Employees

Web

https://www.quincetx.com